BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 17210689)

  • 1. Fas gene mutation in the progression of adult T cell leukemia.
    Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
    J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Fas gene expression in HeLa cells as determined by modified RT-PCR.
    Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kimura S; Koike K
    Cell Mol Life Sci; 1998 Feb; 54(2):186-90. PubMed ID: 9539962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways.
    Kenji SF; Kurma K; Collet B; Oblet C; Debure L; Di Primo C; Minder L; Vérité F; Danger Y; Jean M; Penna A; Levoin N; Legembre P
    Cell Death Dis; 2022 Oct; 13(10):895. PubMed ID: 36274061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity.
    Daburon S; Devaud C; Costet P; Morello A; Garrigue-Antar L; Maillasson M; Hargous N; Lapaillerie D; Bonneu M; Dechanet-Merville J; Legembre P; Capone M; Moreau JF; Taupin JL
    PLoS One; 2013; 8(1):e54000. PubMed ID: 23326557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts.
    Rao-Bindal K; Zhou Z; Kleinerman ES
    Cell Death Dis; 2012 Aug; 3(8):e369. PubMed ID: 22875006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD95-mediated cell signaling in cancer: mutations and post-translational modulations.
    Tauzin S; Debure L; Moreau JF; Legembre P
    Cell Mol Life Sci; 2012 Apr; 69(8):1261-77. PubMed ID: 22042271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.
    Guidicelli G; Chaigne-Delalande B; Dilhuydy MS; Pinson B; Mahfouf W; Pasquet JM; Mahon FX; Pourquier P; Moreau JF; Legembre P
    PLoS One; 2009; 4(5):e5493. PubMed ID: 19430526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update.
    Wang M; Su P
    Syst Biol Reprod Med; 2018 Apr; 64(2):93-102. PubMed ID: 29299971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogens.
    Caulfield AJ; Lathem WW
    PLoS Pathog; 2014 Aug; 10(8):e1004252. PubMed ID: 25101900
    [No Abstract]   [Full Text] [Related]  

  • 10. Dominant-negative Fas mutation is reversed by down-expression of c-FLIP.
    Bénéteau M; Daburon S; Moreau JF; Taupin JL; Legembre P
    Cancer Res; 2007 Jan; 67(1):108-15. PubMed ID: 17210689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis.
    Stel AJ; Ten Cate B; Jacobs S; Kok JW; Spierings DC; Dondorff M; Helfrich W; Kluin-Nelemans HC; de Leij LF; Withoff S; Kroesen BJ
    J Immunol; 2007 Feb; 178(4):2287-95. PubMed ID: 17277134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege.
    Rajashekhar G; Loganath A; Roy AC; Mongelli JM
    Gynecol Oncol; 2003 Oct; 91(1):89-100. PubMed ID: 14529667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation.
    Wang L; Azad N; Kongkaneramit L; Chen F; Lu Y; Jiang BH; Rojanasakul Y
    J Immunol; 2008 Mar; 180(5):3072-80. PubMed ID: 18292530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
    Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
    Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.
    Li X; Xu F; Karoopongse E; Marcondes AM; Lee K; Kowdley KV; Miao CH; Trobridge GD; Campbell JS; Deeg HJ
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1210-9. PubMed ID: 23707854
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.